PRGO NYSE
Perrigo Company plc
1W: -7.5%
1M: -1.6%
3M: +28.6%
YTD: +4.9%
1Y: -35.2%
3Y: -49.8%
5Y: -61.0%
$14.26
+0.24 (+1.71%)
Weekly Expected Move ±7.0%
$12
$13
$14
$15
$16
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
25 relationships25
As Filer
counterparties named
0
As Counterparty
mentioned by others
5
Rel. Types
2021-07-12
Earliest Filing
2025-07-14
Latest Filing
partner: 10
target: 6
acquirer: 4
investor: 4
customer: 1
Counterparties (Filed by PRGO)
25 relationshipsCompanies named in PRGO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Kairos Bidco AB | — | acquirer | Acquired all shares in Aco Hud Nordic AB and Dermacosmetics Business assets from Perrigo Company plc. | 2025-07-14 | View |
| KKR & Co., Inc. | KKRS | investor | Investment vehicle managed by an affiliate of KKR manages the investment vehicle Kairos Bidco AB. | 2025-07-14 | View |
| Aco Hud Nordic AB | — | target | Swedish private corporation whose shares were acquired by Kairos Bidco AB as part of the transaction. | 2025-07-14 | View |
| PNC Capital Markets LLC | — | partner | Acted as an underwriter for the Notes offering. | 2024-09-17 | View |
| Computershare Trust Company, N.A. | — | partner | Served as trustee for the supplemental indentures regarding the new Senior Notes offering. | 2024-09-17 | View |
| Wells Fargo Bank, National Association | — | partner | Served as trustee for the base indenture prior to Computershare taking over. | 2024-09-17 | View |
| ING Financial Markets LLC | — | partner | Acted as an underwriter for the Notes offering. | 2024-09-17 | View |
| Morgan Stanley & Co. LLC | MS-PL | partner | Acted as an underwriter for the Notes offering. | 2024-09-17 | View |
| Goldman Sachs & Co. LLC | GSCE | partner | Acted as an underwriter for the Notes offering. | 2024-09-17 | View |
| Mizuho International plc | — | partner | Acted as an underwriter for the Notes offering. | 2024-09-17 | View |
| Goodbody Stockbrokers UC | — | partner | Acted as an underwriter for the Notes offering. | 2024-09-17 | View |
| Héra SAS | — | target | Target company acquired by Perrigo Company plc on April 29, 2022. | 2022-07-15 | View |
| Habsont Unlimited Company | — | acquirer | Wholly owned subsidiary of Perrigo Company plc that completed the acquisition of HRA from Astorg Partners and Goldman Sa | 2022-05-02 | View |
| Héra SAS | — | target | Target company whose equity interests were acquired by Habsont Unlimited Company. | 2022-05-02 | View |
| Goldman Sachs | GSCE | target | Private equity arm that sold Héra SAS. | 2022-05-02 | View |
| Astorg Partners | — | target | Private equity firm affiliated with funds that sold Héra SAS. | 2022-05-02 | View |
| Perrigo Finance Unlimited Company | — | partner | Wholly-owned finance subsidiary of the Company that entered into the credit agreements. | 2022-04-20 | View |
| Perrigo Investments, LLC | — | partner | Indirect wholly-owned subsidiary that incurred the new senior secured credit facilities. | 2022-04-20 | View |
| Perrigo Holding N.V. | — | customer | Issuer of the 5.1045% Guaranteed Senior Notes due 2023 that were redeemed by the Company. | 2022-04-20 | View |
| Habsont Unlimited Company | — | acquirer | Wholly owned subsidiary of Perrigo Company plc committed to acquire Héra SAS | 2021-09-09 | View |
| Héra SAS | — | target | Target company whose equity interests are being acquired by Habsont Unlimited Company | 2021-09-09 | View |
| Astorg | — | investor | Private equity firm affiliated with the sellers in the acquisition | 2021-09-09 | View |
| Goldman Sachs Asset Management | GSCE | investor | Financial firm affiliated with the sellers in the acquisition | 2021-09-09 | View |
| Altaris Capital Partners, LLC | — | investor | Affiliate of Padagis LLC, the buyer of Perrigo's Generic Rx Pharmaceuticals business | 2021-07-12 | View |
| Padagis LLC | — | acquirer | Acquired Perrigo Company plc's Generic Rx Pharmaceuticals business for $1.55 billion | 2021-07-12 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-07-06 | Officer/Director Change; Exhibits | View | |
| 2026-07-06 | Officer/Director Change | View | |
| 2026-06-30 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-06-08 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-05-05 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-04-30 | Acquisition/Disposition; Regulation FD; Exhibits | Acquisition | View |
| 2026-04-22 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-03-23 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-05 | Results of Operations and Financial Condition; Regulation FD Disclosure | View | |
| 2025-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-14 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-07-01 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-06-04 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-05-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-05 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-02-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-26 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR